Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-24-000468
Filing Date
2024-01-03
Accepted
2024-01-03 17:01:31
Documents
1
Period of Report
2024-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3831
  Complete submission text file 0001140361-24-000468.txt   5621
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Issuer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ETERNA THERAPEUTICS INC. 1035 CAMBRIDGE STREET, STE. 18A CAMBRIDGE MA 02141
Business Address
Clarke Dorothy J (Reporting) CIK: 0001992152 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-11460 | Film No.: 24507880